摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Cyclohexanol, 2-methyl-, 3,5-dinitrobenzoate, cis- | 1161-14-4

中文名称
——
中文别名
——
英文名称
Cyclohexanol, 2-methyl-, 3,5-dinitrobenzoate, cis-
英文别名
Cyclohexanol, 2-methyl-, 3,5-dinitrobenzoate, trans-;cis-2-Methyl-cyclohexanol-(3,5-dinitrobenzoat)
Cyclohexanol, 2-methyl-, 3,5-dinitrobenzoate, cis-化学式
CAS
1161-14-4;1161-15-5;1639-90-3;21531-24-8;21531-25-9;93045-92-2
化学式
C14H16N2O6
mdl
——
分子量
308.291
InChiKey
MXIMPAHNULMORD-TVQRCGJNSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.24
  • 重原子数:
    22.0
  • 可旋转键数:
    4.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    112.58
  • 氢给体数:
    0.0
  • 氢受体数:
    6.0

反应信息

点击查看最新优质反应信息

文献信息

  • Premarketing Surveillance of Oral Ibuprofen Solution in Febrile Children
    作者:M. Berkovitch、J. Press、M. Bulkowstein、L. Even、J. Barash、R. Brik、D. Tasher、R. Marom、A.S. Luder、Y. Hecht、M. Rubinshtein、M. Mosleh、S. Ben-Shachar、R. Talmor、A. Zviel、A. Kiro、L. Piglansky、V. Pinsk、Y. Uziel
    DOI:10.2165/00044011-200121120-00004
    日期:——
    Ibuprofen is as effective as paracetamol (acetaminophen) as an antipyretic and analgesic agent in paediatric patients. Ibuprofen is considered to be well tolerated; however, there are reports on gastrointestinal bleeding or renal adverse effects among children treated with ibuprofen. Oral ibuprofen suspension was recently registered and approved by the Ministry of Health in Israel as an antipyretic and analgesic agent. Before distribution of the drug to pharmacies, we aimed to follow possible adverse effects among children receiving ibuprofen suspension in several paediatric wards and clinics. Children with fever needing antipyretic medication received ibuprofen oral suspension 5 to 10 mg/kg/dose. In each case the age of the patient, gender, diagnosis, number of ibuprofen doses, duration of treatment and any adverse reactions were reported. 1564 children from 14 paediatric wards (11 hospitals) and from five paediatric and family clinics participated in the study; 882 males and 682 females. The patients, aged 3.6 ± 4.2 years (range 1 month to 16.5 years), received 2.4 ± 3 (range 1 to 22) doses of ibuprofen suspension for 1.56 ± 2.11 (range 1 to 20) days. Adverse reactions were reported among 26 patients (1.66%) [95% confidence interval (CI) 1.1–2.4]; 18 children (1.15%) [95% CI 0.7–1.8] vomited immediately after the administration of the drug and it was not readministered. Two children (0.12%) [95% CI 0.02–0.46] had abdominal pain that resolved spontaneously, two patients reported nausea, and two other children had diarrhoea. Eight children (0.51%) reported experiencing a ‘bitter taste’ from the medication, of whom one patient discontinued the medication while the other seven continued it. The adverse reactions following administration of oral ibuprofen suspension reported in our study were low in frequency, mild and disappeared spontaneously. However, continuing reporting on its tolerability is needed.
    布洛芬在小儿患者中作为退烧和止痛药与对乙酰氨基酚扑热息痛)同样有效。布洛芬被认为耐受性良好,然而,有报道显示在接受布洛芬治疗的儿童中可能出现胃肠道出血或肾脏不良反应。以口服布洛芬悬液的形式,最近在以色列卫生部注册并批准作为退烧和止痛药。在将该药物分发至药房之前,我们旨在跟踪在多个儿科病房和门诊接受布洛芬悬液治疗的儿童可能出现的不良反应。需要使用退烧药的发热儿童接受5至10 mg/kg/剂量的口服布洛芬悬液。在每个案例中,报告了患者的年龄、性别、诊断、布洛芬剂量次数、治疗持续时间及任何不良反应。共有1564名儿童参与了研究,来自14个儿科病房(11家医院)和5个儿科及家庭诊所;其中882名为男性,682名为女性。患者年龄为3.6 ± 4.2岁(范围1个月至16.5岁),使用布洛芬悬液的剂量为2.4 ± 3(范围1至22)剂,疗程为1.56 ± 2.11(范围1至20)天。26名患者(1.66%)报告出现不良反应[95%置信区间(CI)1.1–2.4];18名儿童(1.15%)[95% CI 0.7–1.8]在用药后立即呕吐,且未再次给予药物。两名儿童(0.12%)[95% CI 0.02–0.46]出现腹痛,但自发缓解,另有两名患者报告恶心,还有两名儿童出现腹泻。八名儿童(0.51%)报告服用药物后体验到“苦味”,其中一名患者停止用药,而其他七名继续用药。我们研究中报告的口服布洛芬悬液的不良反应发生率较低,症状轻微且自发消失。然而,仍需持续报告其耐受性。
  • Diastereoselective and Enantioselective Silylation of 2-Arylcyclohexanols
    作者:Li Wang、Ravish K. Akhani、Sheryl L. Wiskur
    DOI:10.1021/acs.orglett.5b00919
    日期:2015.5.15
    The silylation-based kinetic resolution of trans 2-arylcyclohexanols was accomplished by employing a triaryl silyl chloride as the derivatizing reagent with a commercially available isothiourea catalyst. The methodology is selective for the trans diastereomer over the cis, which provides an opportunity to selectively derivatize one stereoisomer out of a mixture of four. By employing this technology, a facile, convenient method to form a highly enantiomerically enriched silylated alcohol was accomplished through a one-pot reduction-silylation sequence that started with a 2-aryl-substituted ketone.
  • Vavon; Perlin; Horeau, Bulletin de la Societe Chimique de France, 1932, vol. <4> 51, p. 644,650
    作者:Vavon、Perlin、Horeau
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫